[Dynamics of immunologic indices in patients with ischemic heart disease on a course of doxazosin therapy].

The authors have studied effects of the course treatment with doxasosine, a selective alpha 1-adrenoblocker, on lipid and immunological indices in 46 male subjects with ischemic heart disease presenting with functional class I-III exertional angina. A significant improvement in indices for lipid metabolism has been shown together with absence of negative influence on parameters characterizing immunologic vigour with no worsening of manifestations of T-cellular immune deficiency. In hypercholesterinemia-free middle-aged subjects, posttreatment alterations in the peripheral blood can be regarded as a result of a positive effect on immunological reactivity.